Treatment of recurrent myelodysplastic syndrome (MDS) after hematopoietic cell transplantation (HCT) remains challenging. We present a 4-year-old girl experiencing early MDS relapse post-HCT treated with a multimodal strategy encompassing a second HCT and innovative targeted therapies. We underscore the potential of a comprehensive treatment approach in managing recurrent pediatric MDS.
Keywords: disease control; hematopoietic stem cell transplantation; myelodysplastic syndromes; relapse.
© 2023 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.